Frencken Group enters its May 14 earnings with a remarkable wind at its back — the stock has surged 29% over the past month to SGD 2.73, driven by an institutional buyer emerging and short sellers retreating in the face of the rally.
The standout development of recent weeks is the appearance of Amova Asset Management as a new substantial shareholder. The fund added 16.5 million shares to reach a 5.3% stake, becoming Frencken's second-largest institutional holder after the founding-connected Precico Holdings. The April 6 news of Amova's emergence — following a similar move into SGX peer Valuetronics — is the clearest catalyst for the price action. It signals deliberate accumulation rather than a momentum trade, and the timing ahead of earnings amplifies the read-through.
The lending market tells a quiet story. Short interest is minimal at just 0.36% of free float, and it has been falling steadily since mid-March when it briefly touched 0.56%. Borrow availability has not been flagged as tight. Cost to borrow has drifted higher over the month — up roughly 73% — but at 3.4% it remains a modest annual rate, not a squeeze signal. Lending utilisation at under 9% confirms there is no meaningful short pressure on the stock. The short score of 30 is low and has barely moved, reinforcing that the borrowing market is a non-event here.
Valuation has re-rated sharply alongside the price. The price-to-book multiple has climbed 0.56 turns over 30 days to 2.24x, and the P/E has expanded by over six turns to 25.3x. Against a mean analyst price target of SGD 2.51, the stock now trades at a modest premium — worth noting, though the gap is not extreme. The EV/EBITDA of 11.7x has been broadly stable over the same window. Factor scores offer a mixed read: the dividend score ranks in the 89th percentile, pointing to income quality, and the 12-month forward EPS growth estimate ranks in the 75th percentile. Days-to-cover ranks in the 80th percentile. Against that, EV/EBIT valuation looks stretched at just the 39th percentile on a cheapness basis — the rally has consumed much of the value cushion.
On the insider side, the picture is mixed rather than uniformly bullish. Chairman Soon Chai Gooi has been a small but consistent seller at each quarterly interval since late 2025, trimming 5,000 to 10,000 shares per transaction. The CEO, Mohamad Anwar Au, sold 70,000 shares at SGD 2.15 on April 7 — still well below the current price, meaning those sales look tactical rather than alarmed. The 90-day net insider position is positive at roughly 2.57 million shares, almost entirely driven by the Amova financial services entity rather than named executives.
Earnings history adds texture without a clear pattern. The February 2026 full-year results produced a 3% one-day gain. A March event — likely a separate announcement — saw a 5.4% one-day drop. Over five-day windows, reactions have been muted and slightly negative across the last several prints. With the stock now 29% higher than it was a month ago, the May 14 release becomes a test of whether the underlying results justify the re-rating that preceded it.
See the live data behind this article on ORTEX.
Open E28 on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
